share_log

BRIEF-Shenzhen Chipscreen Biosciences Announces NMPA New Drug Approval Of Bilessglu In China

reuters ·  Oct 19, 2021 07:40

Oct 19 (Reuters) - Shenzhen Chipscreen Biosciences Co Ltd

688321.SS :

* SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD - ANNOUNCES NMPA NEW DRUG APPROVAL OF BILESSGLU (CHIGLITAZAR SODIUM TABLETS) FOR ( TYPE 2 DIABETES) IN CHINA

Source text for Eikon: ID:nPn2nXW6va Further company coverage: 688321.SS

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment